References

American Association of Health Plans. AAHP Board of Directors Agreement Between AAHP and NIH for Support of Clinical Trials. Dated December 11, 1998. [http://www.aahp.org/menus/index.cfm?CFID=84873&CFTOKEN=5124]

Ault, T., Director, Bureau of Policy Development, Health Care Financing Administration. 1996. Statement on Investigational Medical Devices, Committee on Governmental Affairs, Permanent Subcommittee on Investigations, U.S. Senate, February 14, 1996.


Barlow, W., S. Taplin, D. Seger, J. Beckord, L. Ichikawa. 1998. Medical Care Costs of Cancer Patients on Protocol . NCI Meeting, Bethesda, MD: July 7.

Bull, J. P. 1959. The historical development of clinical therapeutic trials. J Chronic Dis 10:218–48.


Cochrane Library Controlled Trials Register. 1999. In: The Cochrane Library [database on CD-ROM]. Oxford, England: Update Software, issue 2.


DeParle, N.-A.M., Administrator, Health Care Financing Administration. 1998. Statement on Health Technology Assessment, Labor and Human Resources Committee, Subcommittee on Public Health and Safety, U.S. Senate, March 12, 1998.

Department of Defense 1999. DoD/NCI agreement expands TRICARE benefit to include cancer prevention trials. DoD Worldwide web site. [tricare.osd.mil/main/news/art0706.html]

Department of Defense/National Cancer Institute. 1996. Interagency Agreement Between the Department of Defense and National Cancer Institute for Partnership in Clinical Trials for Cancer.

Department of Veterans Affairs. Worldwide web site, August 1999.

Department of Veterans Affairs/National Cancer Institute. 1997. Interagency Agreement Between the Department of Veterans Affairs and the National Cancer Institute for a Partnership in Clinical Trials for Cancer.

Dickersin, K., and Y.I. Min. 1993. Publication bias: The problem that won't go away. Ann N Y Acad Sci 703:135–46.

Dobson, A., and Sturm, E. 1999. Reimbursement of Routine Patient Care Costs in Clinical Trials. (Report to the Institute of Medicine Committee on Routine Patient Care



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 65
Extending Medicare Reimbursement in Clinical Trials References American Association of Health Plans. AAHP Board of Directors Agreement Between AAHP and NIH for Support of Clinical Trials. Dated December 11, 1998. [http://www.aahp.org/menus/index.cfm?CFID=84873&CFTOKEN=5124] Ault, T., Director, Bureau of Policy Development, Health Care Financing Administration. 1996. Statement on Investigational Medical Devices, Committee on Governmental Affairs, Permanent Subcommittee on Investigations, U.S. Senate, February 14, 1996. Barlow, W., S. Taplin, D. Seger, J. Beckord, L. Ichikawa. 1998. Medical Care Costs of Cancer Patients on Protocol . NCI Meeting, Bethesda, MD: July 7. Bull, J. P. 1959. The historical development of clinical therapeutic trials. J Chronic Dis 10:218–48. Cochrane Library Controlled Trials Register. 1999. In: The Cochrane Library [database on CD-ROM]. Oxford, England: Update Software, issue 2. DeParle, N.-A.M., Administrator, Health Care Financing Administration. 1998. Statement on Health Technology Assessment, Labor and Human Resources Committee, Subcommittee on Public Health and Safety, U.S. Senate, March 12, 1998. Department of Defense 1999. DoD/NCI agreement expands TRICARE benefit to include cancer prevention trials. DoD Worldwide web site. [tricare.osd.mil/main/news/art0706.html] Department of Defense/National Cancer Institute. 1996. Interagency Agreement Between the Department of Defense and National Cancer Institute for Partnership in Clinical Trials for Cancer. Department of Veterans Affairs. Worldwide web site, August 1999. Department of Veterans Affairs/National Cancer Institute. 1997. Interagency Agreement Between the Department of Veterans Affairs and the National Cancer Institute for a Partnership in Clinical Trials for Cancer. Dickersin, K., and Y.I. Min. 1993. Publication bias: The problem that won't go away. Ann N Y Acad Sci 703:135–46. Dobson, A., and Sturm, E. 1999. Reimbursement of Routine Patient Care Costs in Clinical Trials. (Report to the Institute of Medicine Committee on Routine Patient Care

OCR for page 65
Extending Medicare Reimbursement in Clinical Trials Costs in Clinical Trials for Medicare Beneficiaries.) The Lewin Group, Fairfax, Va., 1999. Doll, R. 1982. Clinical trials: Retrospect and prospect. Star Med 1:337–44. Evans, R. 1992. Public and private insurer designation of transplantation programs. Transplantation 53(5): 1041–6. Fireman, B., L. Fehrenbacher, L. Gruskin, and T. Ray. 1998. The Cost of Care in Cancer Clinical Trials at Kaiser Permanente, Northern California. NCI Meeting, Bethesda MD: July 7. Fisher, R. A. 1926. The arrangement of field experiments. J Ministry Agricult Gt Brit 33:503–13. Fisher, R. A. 1935. The Design of Experiments. Edinburgh: Oliver and Boyd. Hartwig, J. E. 1996. Medical Coverage of Investigational Devices. Testimony Before the Committee on Governmental Affairs, Permanent Subcommittee on Investigations, U.S. Senate, February 14, 1996. Health Care Financing Administration/Food and Drug Administration. 1995. Interagency Agreement Between the Food and Drug Administration and the Health Care Financing Administration Regarding Medicare Coverage of Certain Investigational Medical Devices (IDE Memorandum D95-2). Photocopy. Hennekens, C. H., and J. E. Buring. 1987. Epidemiology in Medicine . Boston: Little, Brown, and Co. Holohan, T. V., and H. Handelsman. 1996. Lung-volume reduction surgery for end-stage chronic obstructive pulmonary disease. Health Technol Assess (Rocky) 10(Sept.): 1–30. Lilienfeld, A.M. 1982. Ceteris paribus: The evolution of the clinical trial. Bull Hist Med 56: 1–18. McCray, A. National Library of Medicine, NIH. 1999. Personal communication to H. Gelband. Medical Research Council. 1948. Streptomycin treatment of pulmonary tuberculosis. BMJ 2:769–82. Meinert, C. L. 1986. Clinical Trials: Design, Conduct, and Analysis . Oxford: Oxford University Press, pp. 3–10. Newcomer, L. 1999. Medical Director, United Health Group, personal communication, August 1999. O'Rourke, P. 1999. Office of the Director, NIH. Personal communication to Hellen Gelband. Szymanski, J. 1999. Office of the Assistant Secretary of Defense (Health Affairs), personal communication, October 1999. U.S. General Accounting Office. 1997. Cancer Clinical Trials: Medicare Reimbursement Denials (GAO/HEHS-98-15R). Washington, D.C.: GAO. U.S. General Accounting Office. 1999. NIH Clinical Trials: Various Factors Affect Patient Participation (GAO/HEHS-99-182). Washington, D.C.: GAO. Wagner, J. L., S. R. Alberts, J. A. Sloan, S. Cha, J. Killian, M. J. O'Connell et al. 1999. Incremental costs of enrolling cancer patients in clinical trials: A population-based study. J Natl Cancer Inst 91(10):847–53. Zelen, M. 1993. Large simple trials. In Clinical Trials and Statistics: Proceedings of a Symposium. Washington, D.C.: National Academy Press.